Skip to main content
Top
Published in: Globalization and Health 1/2011

Open Access 01-12-2011 | Commentary

HIV as a chronic disease considerations for service planning in resource-poor settings

Author: Lucy Reynolds

Published in: Globalization and Health | Issue 1/2011

Login to get access

Abstract

This paper reviews the healthcare issues facing nations which have a substantial caseload of chronic HIV cases. It considers the challenges of extending antiretroviral coverage to an expanding caseload as supplier price rises and international trade agreements come into force to reduce the availability of affordable antiretrovirals just as the economic downturn restricts donor funding. It goes on to review the importance in this context of supporting adherence to drug regimens in order to preserve access to affordable antiretrovirals for those already on treatment, and of removing key barriers such as patient fees and supply interruptions. The demands of those with chronic HIV for health services other than antiretroviral therapy are considered in the light of the fearful or discriminatory attitudes of non-specialist healthcare staff due to HIV-related stigma, which is linked with the weakness of infection control measures in many health facilities. The implications for prevention strategies including those involving criminalisation of HIV transmission or exposure are briefly summarised for the current context, in which the caseload of those whose chronic HIV infection must be controlled with antiretrovirals will continue to rise for the foreseeable future.
Literature
2.
go back to reference Voice of America News: Proposed budget cuts could threaten. PEPFAR. 2011 Voice of America News: Proposed budget cuts could threaten. PEPFAR. 2011
4.
go back to reference Holmes CB, Coggin W, Jamieson D, Mihm H, Granich R, Savio P, Hope M, Ryan C, Moloney-Kitts M, Goosby EP, Dybul M: Use of generic antiretroviral agents and cost savings in PEPFAR treatment programmes. JAMA. 2010, 304 (3): 313-320. 10.1001/jama.2010.993.CrossRefPubMed Holmes CB, Coggin W, Jamieson D, Mihm H, Granich R, Savio P, Hope M, Ryan C, Moloney-Kitts M, Goosby EP, Dybul M: Use of generic antiretroviral agents and cost savings in PEPFAR treatment programmes. JAMA. 2010, 304 (3): 313-320. 10.1001/jama.2010.993.CrossRefPubMed
5.
go back to reference Waning B, Diedrichsen E, Moon S: A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries. J Int AIDS Soc. 2010, 13: 35-10.1186/1758-2652-13-35.CrossRefPubMedPubMedCentral Waning B, Diedrichsen E, Moon S: A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries. J Int AIDS Soc. 2010, 13: 35-10.1186/1758-2652-13-35.CrossRefPubMedPubMedCentral
6.
go back to reference Grover A, Citro B: India: access to affordable drugs and the right to health. The Lancet. 2011 Grover A, Citro B: India: access to affordable drugs and the right to health. The Lancet. 2011
7.
go back to reference Ihucha A: Worry for AIDS patients ahead of EU-India deal. The Citizen. 2010, Tanzania Ihucha A: Worry for AIDS patients ahead of EU-India deal. The Citizen. 2010, Tanzania
9.
go back to reference Rapid advice: Antiretroviral therapy for HIV infection in adults and adolescents. WHO. 2009 Rapid advice: Antiretroviral therapy for HIV infection in adults and adolescents. WHO. 2009
10.
go back to reference Stead D, Osler M, Boulle A, Rebe K, Meintjes G: Severe hyperlactaemia complicating stavudine first-line antiretroviral therapy in South Africa. Antivir Ther. 2008, 13 (7): 937-43.PubMed Stead D, Osler M, Boulle A, Rebe K, Meintjes G: Severe hyperlactaemia complicating stavudine first-line antiretroviral therapy in South Africa. Antivir Ther. 2008, 13 (7): 937-43.PubMed
11.
go back to reference Colebunders R, Kamya MR, Laurence J, Kambugu A, Byakwaga H, Mwebaze PS, Muganga AM, Katwere M, Katabira E: First-line antiretroviral therapy in Africa - how evidence-based are our recommendations?. AIDS Reviews. 2005, 7: 148-54.PubMed Colebunders R, Kamya MR, Laurence J, Kambugu A, Byakwaga H, Mwebaze PS, Muganga AM, Katwere M, Katabira E: First-line antiretroviral therapy in Africa - how evidence-based are our recommendations?. AIDS Reviews. 2005, 7: 148-54.PubMed
12.
go back to reference Rosen S, Long L, Fox M, Sanne I: Tenofovir in First-Line ARV regimens in South Africa. 15th Conference on Retroviruses and Opportunistic Infections, Boston USA 3-6. 2006, February Rosen S, Long L, Fox M, Sanne I: Tenofovir in First-Line ARV regimens in South Africa. 15th Conference on Retroviruses and Opportunistic Infections, Boston USA 3-6. 2006, February
14.
go back to reference Ontebetse K: Batswana to pay for ARVs. The Botswana Gazette. 2010 Ontebetse K: Batswana to pay for ARVs. The Botswana Gazette. 2010
15.
go back to reference Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J, Kebaabetswe P, Dickenson D, Essex M, Marlink R: Barriers to Antiretroviral Adherence for Patients Living with HIV Infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003, 34 (3): Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J, Kebaabetswe P, Dickenson D, Essex M, Marlink R: Barriers to Antiretroviral Adherence for Patients Living with HIV Infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003, 34 (3):
16.
go back to reference Ware NC, Wyatt MA, Tugenberg T: Social relationships, stigma and adherence to antiretroviral therapy for HIV/AIDS. AIDS Care. 2006, 18 (8): 904-910. 10.1080/09540120500330554.CrossRefPubMed Ware NC, Wyatt MA, Tugenberg T: Social relationships, stigma and adherence to antiretroviral therapy for HIV/AIDS. AIDS Care. 2006, 18 (8): 904-910. 10.1080/09540120500330554.CrossRefPubMed
17.
go back to reference Ramadhani H, Thielman NM, Landman KZ, Ndosi EM, Gao F, Kirchherr JL, Shah R, Shao HJ, Morpeth SC, McNeill JD, Shao JF, Bartlett JA, Crump JA: Predictors of Incomplete Adherence, Virologic Failure, and Antiviral Drug Resistance among HIV-Infected Adults Receiving Antiretroviral Therapy in Tanzania. CID. 2007, 45: 1492-1498. 10.1086/522991.CrossRef Ramadhani H, Thielman NM, Landman KZ, Ndosi EM, Gao F, Kirchherr JL, Shah R, Shao HJ, Morpeth SC, McNeill JD, Shao JF, Bartlett JA, Crump JA: Predictors of Incomplete Adherence, Virologic Failure, and Antiviral Drug Resistance among HIV-Infected Adults Receiving Antiretroviral Therapy in Tanzania. CID. 2007, 45: 1492-1498. 10.1086/522991.CrossRef
18.
go back to reference Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000, 133: 21-30.CrossRefPubMed Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000, 133: 21-30.CrossRefPubMed
19.
go back to reference Gross R, Bilker WB, Friedman HM, Strom BL: Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS. 2001, 15: 2109-2117. 10.1097/00002030-200111090-00006.CrossRefPubMed Gross R, Bilker WB, Friedman HM, Strom BL: Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS. 2001, 15: 2109-2117. 10.1097/00002030-200111090-00006.CrossRefPubMed
20.
go back to reference Orrell C, Bangsberg DR, Badri M, Wood R: Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS. 2003, 17: 1369-1375. 10.1097/00002030-200306130-00011.CrossRefPubMed Orrell C, Bangsberg DR, Badri M, Wood R: Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS. 2003, 17: 1369-1375. 10.1097/00002030-200306130-00011.CrossRefPubMed
21.
go back to reference Van Dyke RB, Lee S, Johnson GM, Wiznia A, Mohan K, Stanley K, et al: Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics. 2002, 109: e61-10.1542/peds.109.4.e61.CrossRefPubMed Van Dyke RB, Lee S, Johnson GM, Wiznia A, Mohan K, Stanley K, et al: Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics. 2002, 109: e61-10.1542/peds.109.4.e61.CrossRefPubMed
22.
go back to reference Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, et al: Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000, 14: 357-366. 10.1097/00002030-200003100-00008.CrossRefPubMed Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, et al: Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000, 14: 357-366. 10.1097/00002030-200003100-00008.CrossRefPubMed
23.
go back to reference Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O'Shaughnessy MV, et al: Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS. 2002, 16: 1051-1058. 10.1097/00002030-200205030-00012.CrossRefPubMed Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O'Shaughnessy MV, et al: Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS. 2002, 16: 1051-1058. 10.1097/00002030-200205030-00012.CrossRefPubMed
24.
go back to reference Kranzer K, Ford N: Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review. Tropical Medicine and International Health. 2011 Kranzer K, Ford N: Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review. Tropical Medicine and International Health. 2011
25.
go back to reference Jaffar S, Amuron B, Foster S, et al: Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. The Lancet. 2009, 374 (9707): 2080-2089. 10.1016/S0140-6736(09)61674-3.CrossRef Jaffar S, Amuron B, Foster S, et al: Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. The Lancet. 2009, 374 (9707): 2080-2089. 10.1016/S0140-6736(09)61674-3.CrossRef
26.
go back to reference Allen C, Mbonye M, Seeley J, Birungi J, Wolff B, Coutinho A, Jaffar S: ABC for people with HIV: responses to sexual behaviour recommendations among people receiving antiretroviral therapy in Jinja, Uganda. Culture, Health & Sexuality. 2011, 13 (05): 529-543. 10.1080/13691058.2011.558593.CrossRef Allen C, Mbonye M, Seeley J, Birungi J, Wolff B, Coutinho A, Jaffar S: ABC for people with HIV: responses to sexual behaviour recommendations among people receiving antiretroviral therapy in Jinja, Uganda. Culture, Health & Sexuality. 2011, 13 (05): 529-543. 10.1080/13691058.2011.558593.CrossRef
27.
go back to reference Castro A, Farmer PE: Adherence and cost of treatment: The need for a biosocial approach in the understanding of user-fees and its impact on adherence to antiretrovirals. Int Conf AIDS. 2004, 15: WePeB5809- Castro A, Farmer PE: Adherence and cost of treatment: The need for a biosocial approach in the understanding of user-fees and its impact on adherence to antiretrovirals. Int Conf AIDS. 2004, 15: WePeB5809-
28.
go back to reference Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, Bangsberg DR: Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. Int J STD AIDS. 2005, 16 (1): 38-41. 10.1258/0956462052932548.CrossRefPubMed Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, Bangsberg DR: Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. Int J STD AIDS. 2005, 16 (1): 38-41. 10.1258/0956462052932548.CrossRefPubMed
29.
go back to reference Shah B, Walshe L, Saple DG, Mehta SH, Ramnani JP, Kharkar RD, Bollinger RC, Gupta A: Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. Clin Inf Dis. 2007, 44: 1235-1244. 10.1086/513429.CrossRef Shah B, Walshe L, Saple DG, Mehta SH, Ramnani JP, Kharkar RD, Bollinger RC, Gupta A: Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. Clin Inf Dis. 2007, 44: 1235-1244. 10.1086/513429.CrossRef
31.
go back to reference Ghana Government Portal: Emergency antiretroviral drugs for Ghana. 2011 Ghana Government Portal: Emergency antiretroviral drugs for Ghana. 2011
32.
go back to reference Soir Algerie: Rupture des antirétroviraux: Des personnes atteintes du VIH/SIDA protestent à Oran. 28 July 2011-07-31 Soir Algerie: Rupture des antirétroviraux: Des personnes atteintes du VIH/SIDA protestent à Oran. 28 July 2011-07-31
33.
go back to reference 2011, Associated Press. Swaziland: thousands protest in tiny kingdom over wage cuts, HIV drug shortages for 2nd day 2011, Associated Press. Swaziland: thousands protest in tiny kingdom over wage cuts, HIV drug shortages for 2nd day
34.
go back to reference Ross AC, et al: Relationship between inflammatory markers, endothelial activation markers and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy. Clin Infect Dis. 2009, 49 (7): 1119-1126. 10.1086/605578.CrossRefPubMedPubMedCentral Ross AC, et al: Relationship between inflammatory markers, endothelial activation markers and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy. Clin Infect Dis. 2009, 49 (7): 1119-1126. 10.1086/605578.CrossRefPubMedPubMedCentral
35.
go back to reference Choi AI, et al: HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy. AIDS. 2009, 23 (16): 2143-2149. 10.1097/QAD.0b013e3283313c91.CrossRefPubMedPubMedCentral Choi AI, et al: HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy. AIDS. 2009, 23 (16): 2143-2149. 10.1097/QAD.0b013e3283313c91.CrossRefPubMedPubMedCentral
36.
go back to reference Ellis R: Higher CD4 nadir is associated with reduced rates of HIV-associated neurocognitive disorders in the CHARTER study: potential implications for early treatment initiation. 17th Conference on Retroviruses and Opportunistic Infections, San Francisco. 2010, 429- Ellis R: Higher CD4 nadir is associated with reduced rates of HIV-associated neurocognitive disorders in the CHARTER study: potential implications for early treatment initiation. 17th Conference on Retroviruses and Opportunistic Infections, San Francisco. 2010, 429-
37.
go back to reference Mahendra VS, Gilborn L, Bharat S, Mudoi R, Gupta I, George B, Samson L, Daly C, Pulerwitz J: Understanding and measuring AIDS-related stigma in health care settings: a developing country perspective. Journal of Social Aspects of HIV/AIDS. 2007, 4: 616-625.CrossRefPubMed Mahendra VS, Gilborn L, Bharat S, Mudoi R, Gupta I, George B, Samson L, Daly C, Pulerwitz J: Understanding and measuring AIDS-related stigma in health care settings: a developing country perspective. Journal of Social Aspects of HIV/AIDS. 2007, 4: 616-625.CrossRefPubMed
38.
go back to reference Ebrahim Z: When Men Fear Telling Their Wives About HIV. 30/12/2010 Inter Press Service Ebrahim Z: When Men Fear Telling Their Wives About HIV. 30/12/2010 Inter Press Service
40.
go back to reference Reynolds L, Hows J Strazdins E: HIV-related Stigma Measures and Measurement Tools: Consultation with PLHIV to contribute to the development of common indicators. Global Network of People Living with HIV. 2010 Reynolds L, Hows J Strazdins E: HIV-related Stigma Measures and Measurement Tools: Consultation with PLHIV to contribute to the development of common indicators. Global Network of People Living with HIV. 2010
42.
go back to reference Ministry of Health and National Institute of Statistics: Inquerito nacional de prevalencia, riscos comportamentais e informacao sobre o HIV e SIDA em Mocambique (INSIDA) 2009. 2010, Maputo Mocambique Ministry of Health and National Institute of Statistics: Inquerito nacional de prevalencia, riscos comportamentais e informacao sobre o HIV e SIDA em Mocambique (INSIDA) 2009. 2010, Maputo Mocambique
43.
go back to reference Okinyi M, Brewer DD, Potterat JJ: Horizontally-acquired infection in Kenyan and Swazi children. International Journal of STD AIDS. 20 (12): 852-857. Okinyi M, Brewer DD, Potterat JJ: Horizontally-acquired infection in Kenyan and Swazi children. International Journal of STD AIDS. 20 (12): 852-857.
44.
go back to reference Mann JM, Francis H, Davichi F, Baudoux P, Quinn TC, Nzilambi N, Bosenge N, Colebunders RL, Piot P, Kabote N, et al: Risk factors for human immunodeficiency virus seropositivity among children 1-24 months old in Kinshasa, Zaire. Lancet. 1986, 2: 654-657.CrossRefPubMed Mann JM, Francis H, Davichi F, Baudoux P, Quinn TC, Nzilambi N, Bosenge N, Colebunders RL, Piot P, Kabote N, et al: Risk factors for human immunodeficiency virus seropositivity among children 1-24 months old in Kinshasa, Zaire. Lancet. 1986, 2: 654-657.CrossRefPubMed
45.
go back to reference Shisana O, Connolly C, Rehle TM, Mehtar S, Dana P: HIV risk exposure among South African children in public health facilities. AIDS Care. 2008, 20: 755-763. 10.1080/09540120701771705.CrossRefPubMed Shisana O, Connolly C, Rehle TM, Mehtar S, Dana P: HIV risk exposure among South African children in public health facilities. AIDS Care. 2008, 20: 755-763. 10.1080/09540120701771705.CrossRefPubMed
46.
go back to reference Peabody JW: Economic reform and health sector policy: lessons from structural adjustment programs. Social Science Medicine. 1996, 43 (5): 823-835. 10.1016/0277-9536(96)00127-X.CrossRefPubMed Peabody JW: Economic reform and health sector policy: lessons from structural adjustment programs. Social Science Medicine. 1996, 43 (5): 823-835. 10.1016/0277-9536(96)00127-X.CrossRefPubMed
47.
go back to reference Turshen M: Privatizing health services in Africa. 1999, New Jersey Rutgers Press Turshen M: Privatizing health services in Africa. 1999, New Jersey Rutgers Press
48.
go back to reference WHO: Considerations for implementing models for optimising the volume and efficiency of male circumcision services. 2010, World Health Organisation, Geneva WHO: Considerations for implementing models for optimising the volume and efficiency of male circumcision services. 2010, World Health Organisation, Geneva
49.
go back to reference Herek GM, Capitanio JP: AIDS Stigma and contact with persons with AIDS: effect of direct and vicarious contact. Journal of Applied Sociology. 1997, 217 (1): 1-36. Herek GM, Capitanio JP: AIDS Stigma and contact with persons with AIDS: effect of direct and vicarious contact. Journal of Applied Sociology. 1997, 217 (1): 1-36.
50.
go back to reference Paxton S: The Impact of Utilizing HIV-Positive Speakers in AIDS Education. AIDS Education and Prevention. 2002, 14 (4): 282-294. 10.1521/aeap.14.5.282.23874.CrossRefPubMed Paxton S: The Impact of Utilizing HIV-Positive Speakers in AIDS Education. AIDS Education and Prevention. 2002, 14 (4): 282-294. 10.1521/aeap.14.5.282.23874.CrossRefPubMed
51.
go back to reference Takai A, Wongkhomthong S, Akabayashi A, Kai I, Ohi G, Naka K: Correlation between history of contact with people living with HIV/AIDS (PWAs) and tolerant attitudes toward HIV/AIDS and PWAs in rural Thailand. International Journal of STD and AIDS. 1998, 9 (8): 482-484. 10.1258/0956462981922548.CrossRefPubMed Takai A, Wongkhomthong S, Akabayashi A, Kai I, Ohi G, Naka K: Correlation between history of contact with people living with HIV/AIDS (PWAs) and tolerant attitudes toward HIV/AIDS and PWAs in rural Thailand. International Journal of STD and AIDS. 1998, 9 (8): 482-484. 10.1258/0956462981922548.CrossRefPubMed
52.
go back to reference Cameron S, Reynolds L: The Global Criminalisation Scan Report 2010. Documenting trends, presenting evidence. Global Network of People living with HIV/AIDS, GNP+. 2010, Amsterdam Cameron S, Reynolds L: The Global Criminalisation Scan Report 2010. Documenting trends, presenting evidence. Global Network of People living with HIV/AIDS, GNP+. 2010, Amsterdam
54.
55.
go back to reference Cohen MS: HIV treatment as prevention and the "Swiss Statement": in for a dime, in for a dollar?. Clin Infect Dis. 2010, 51: 1323-24. 10.1086/656810.CrossRefPubMed Cohen MS: HIV treatment as prevention and the "Swiss Statement": in for a dime, in for a dollar?. Clin Infect Dis. 2010, 51: 1323-24. 10.1086/656810.CrossRefPubMed
56.
go back to reference Gorbach PM, et al: Behaviors of recently HIV-infected men who have sex with men in the year post-diagnosis: effects of drug use and partner types. J Acquir Immune Defic Syndr. 2010, online edition Gorbach PM, et al: Behaviors of recently HIV-infected men who have sex with men in the year post-diagnosis: effects of drug use and partner types. J Acquir Immune Defic Syndr. 2010, online edition
57.
go back to reference Allen C, Mbonye M, Seeley J, Birungi J, Wolff B, Coutinho A, Jaffaer S: ABC for people with HIV: responses to sexual behaviour recommendations among people receiving antiretroviral therapy in Jinja, Uganda. Culture, Health and Sexuality. 2011, 13 (5): 529-543. 10.1080/13691058.2011.558593.CrossRefPubMedPubMedCentral Allen C, Mbonye M, Seeley J, Birungi J, Wolff B, Coutinho A, Jaffaer S: ABC for people with HIV: responses to sexual behaviour recommendations among people receiving antiretroviral therapy in Jinja, Uganda. Culture, Health and Sexuality. 2011, 13 (5): 529-543. 10.1080/13691058.2011.558593.CrossRefPubMedPubMedCentral
Metadata
Title
HIV as a chronic disease considerations for service planning in resource-poor settings
Author
Lucy Reynolds
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Globalization and Health / Issue 1/2011
Electronic ISSN: 1744-8603
DOI
https://doi.org/10.1186/1744-8603-7-35

Other articles of this Issue 1/2011

Globalization and Health 1/2011 Go to the issue